A Retrospective Cohort Study of Treatment Outcomes of Adult Patients with Relapsed or Refractory Low-Grade Follicular Lymphoma (ReCORD-FL)

被引：5
|
作者：
Salles, Gilles
Schuster, Stephen J.
Fischer, Luca
Kuruvilla, John
Patten, Piers E. M.
Tresckow, Bastianvon
Smith, Sonali M.
Jiminez Ubieto, Ana Isabel
Davis, Keith L.
Nagar, Saurabh P.
Zhang, Jie
Bollu, Vamsi
Jousseaume, Etienne
Ramos, Roberto
Wang, Yucai
Link, Brian K.
机构：
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-145870
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1349
引用
收藏
页数：6
相关论文
共 50 条
  • [31] ETHNIC SENSITIVITY ASSESSMENT OF MOSUNETUZUMAB PHARMACOKINETICS (PK) IN CHINESE PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (FL).
    Liao, M.
    Li, J.
    Wilkins, J.
    Wang, B.
    Vadhavkar, S.
    Peng, K.
    Zhang, Y.
    Li, D.
    Zhou, M.
    Li, C.
    Li, C.
    Turner, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S12 - S12
  • [32] Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study
    Casadei, Beatrice
    Argnani, Lisa
    Broccoli, Alessandro
    Patti, Caterina
    Stefani, Piero Maria
    Cuneo, Antonio
    Margiotta Casaluci, Gloria
    Visco, Carlo
    Gini, Guido
    Pane, Fabrizio
    D'Alo, Francesco
    Luzi, Debora
    Cantonetti, Maria
    Pozzi, Samantha
    Musuraca, Gerardo
    Rosignoli, Chiara
    Arcari, Annalisa
    Kovalchuk, Sofya
    Tani, Monica
    Tisi, Maria Chiara
    Petrini, Mario
    Stefoni, Vittorio
    Zinzani, Pier Luigi
    CANCERS, 2022, 14 (03)
  • [33] Combination immunotherapy of relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma with rituximab and interferon-α-2a
    Davis, TA
    Maloney, DG
    Grillo-López, AJ
    White, CA
    Williams, ME
    Weiner, GJ
    Dowden, S
    Levy, R
    CLINICAL CANCER RESEARCH, 2000, 6 (07) : 2644 - 2652
  • [34] TREATMENT OF REFRACTORY LOW-GRADE LYMPHOMA WITH CHLORAMBUCIL ALTERNATING WITH INTERFERON AND RADIOTHERAPY
    AVILES, A
    TALAVERA, A
    GUZMAN, R
    CUADRA, I
    CANCER BIOTHERAPY, 1995, 10 (04): : 273 - 277
  • [35] A retrospective study on the management of patients with rituximab refractory follicular lymphoma
    Solal-Celigny, Philippe
    Leconte, Pierre
    Bardet, Aurelie
    Hernandez, Juana
    Troussard, Xavier
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (02) : 217 - 223
  • [36] Allogeneic bone marrow transplantation in patients with relapsed low-grade follicular non-Hodgkin's lymphoma (NHL).
    Mandigers, C
    Raemaekers, J
    Schattenberg, A
    Bogman, J
    Mensink, E
    deWitte, T
    BLOOD, 1995, 86 (10) : 821 - 821
  • [37] Prognostic Factors of Autologous Transplantation in the Treatment of Patients With Relapsed/Refractory Follicular Lymphoma
    Jona, Adam
    Kenyeres, Anna
    Kiss, Evelin
    Illes, Arpad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S384 - S385
  • [38] Current treatment of follicular and low-grade non-Hodgkin's lymphoma
    Linch, D
    ANTI-CANCER DRUGS, 2001, 12 : S5 - S9
  • [39] Patient-Reported Outcomes (PROs) from the Phase 2 TRANSCEND FL Study of Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory Follicular Lymphoma (FL)
    Cartron, Gillaume
    Garcia-Sancho, Alejandro Martin
    Reguera, Juan Luis
    Dahiya, Saurabh
    Guo, Shien
    Shi, Ling
    Eliason, Laurie
    Kumar, Jinender
    Farazi, Thalia
    Fasan, Omotayo
    Izutsu, Koji
    BLOOD, 2023, 142
  • [40] Rituximab treatment in a spondyloarthritis patient with low-grade follicular lymphoma: a case report
    Martins, P.
    Barreira, S. C.
    Lopes, C.
    Fonseca, J. E.
    Resende, C.
    ACTA REUMATOLOGICA PORTUGUESA, 2020, 45 (03): : 227 - 228
12345